The cutthroat battle for the US weight-loss drug market

When Ruth Gonzalez decided to start taking the weight-loss medicine Zepbound last year, she first had to find a way to afford its roughly $350 (£260) monthly cost. Gonzalez switched her mobile phone plan, dropped all but one of her streaming subscriptions, limited her grocery spending and cut out S...

Redirecting to full article...